[Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
D000368:Aged; D000583:Amikacin / Q000627:therapeutic use; D001013:Aorta, Thoracic; D001014:Aortic Aneurysm / Q000150:complications; D002509:Cephaloridine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D008826:Microbial Sensitivity Tests; D010300:Parkinson Disease / Q000150:complications; D011512:Proteus Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D011513:Proteus mirabilis / Q000187:drug effects / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D013345:Subarachnoid Hemorrhage / Q000150:complications
D005839:Gentamicins; D007612:Kanamycin; D000583:Amikacin; D002509:Cephaloridine